Cardiovascular adverse events and immune-related adverse events associated with PD-1/PD-L1 inhibitors for head and neck squamous cell carcinoma (HNSCC)

Cardiovascular adverse events and immune-related adverse events associated with PD-1/PD-L1 inhibitors for head and neck squamous cell carcinoma (HNSCC)

Abstract While some literature has provided limited information about the potential cardiovascular risk and immune-related adverse events (irAEs) risk associated with PD-1/PD-L1 inhibitors in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), the exact relevance is still uncertain. To a...

Full description

Bibliographic Details
Main Authors: Adila Abulizi, Guangpeng Yan, Qian Xu, Reyihanguli Muhetaer, Shihan Wu, Kudelaiti Abudukelimu, Xi Chen, Chengjiang Liu, Jun Li
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Scientific Reports
Subjects:
PD-1/PD-L1 inhibitors
Major adverse cardiovascular events
Immune-related adverse events
HNSCC
FAERS
Online Access:https://doi.org/10.1038/s41598-024-75099-5

Internet

https://doi.org/10.1038/s41598-024-75099-5

Similar Items